These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31585951)

  • 21. High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.
    Morgan RA; Dudley ME; Yu YY; Zheng Z; Robbins PF; Theoret MR; Wunderlich JR; Hughes MS; Restifo NP; Rosenberg SA
    J Immunol; 2003 Sep; 171(6):3287-95. PubMed ID: 12960359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a coordinated CD8 and CD4 T cell response directed against mismatched HLA Class I causing severe acute graft-versus-host disease.
    Amir AL; Hagedoorn RS; van Luxemburg-Heijs SA; Marijt EW; Kruisselbrink AB; Frederik Falkenburg JH; Heemskerk MH
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):210-9. PubMed ID: 22015995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superimposed epitopes restricted by the same HLA molecule drive distinct HIV-specific CD8+ T cell repertoires.
    Sun X; Fujiwara M; Shi Y; Kuse N; Gatanaga H; Appay V; Gao GF; Oka S; Takiguchi M
    J Immunol; 2014 Jul; 193(1):77-84. PubMed ID: 24899498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.
    Nilges K; Höhn H; Pilch H; Neukirch C; Freitag K; Talbot PJ; Maeurer MJ
    J Virol; 2003 May; 77(9):5464-74. PubMed ID: 12692247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01.
    Yun J; Marcaida MJ; Eriksson KK; Jamin H; Fontana S; Pichler WJ; Yerly D
    J Immunol; 2014 Apr; 192(7):2984-93. PubMed ID: 24591375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
    Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
    J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
    Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
    Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing Natural Killer and CD8
    Ravindranath MH; Filippone EJ; Devarajan A; Asgharzadeh S
    Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):38-59. PubMed ID: 31009335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.
    Romagnani C; Pietra G; Falco M; Millo E; Mazzarino P; Biassoni R; Moretta A; Moretta L; Mingari MC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11328-33. PubMed ID: 12167676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel HLA-A*24:02-restricted adenovirus serotype 11-specific CD8+ T-cell epitope for adoptive immunotherapy.
    Imahashi N; Nishida T; Ito Y; Kawada J; Nakazawa Y; Toji S; Suzuki S; Terakura S; Kato T; Murata M; Naoe T
    Mol Immunol; 2013 Dec; 56(4):399-405. PubMed ID: 23911395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low TCR avidity and lack of tumor cell recognition in CD8(+) T cells primed with the CEA-analogue CAP1-6D peptide.
    Iero M; Squarcina P; Romero P; Guillaume P; Scarselli E; Cerino R; Carrabba M; Toutirais O; Parmiani G; Rivoltini L
    Cancer Immunol Immunother; 2007 Dec; 56(12):1979-91. PubMed ID: 17564703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
    Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human CD8 transgene regulation of HLA recognition by murine T cells.
    LaFace DM; Vestberg M; Yang Y; Srivastava R; DiSanto J; Flomenberg N; Brown S; Sherman LA; Peterson PA
    J Exp Med; 1995 Nov; 182(5):1315-25. PubMed ID: 7595202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide.
    Derré L; Ferber M; Touvrey C; Devevre E; Zoete V; Leimgruber A; Romero P; Michielin O; Lévy F; Speiser DE
    J Immunol; 2007 Dec; 179(11):7635-45. PubMed ID: 18025209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of T-cell receptors with a recurrent CDR3β peptide-contact motif within the repertoire of alloreactive CD8(+) T cells.
    Scifo C; Mekaelian L; Munyazesa E; Schmitt-Verhulst AM; Guimezanes A
    Eur J Immunol; 2011 Aug; 41(8):2414-23. PubMed ID: 21590766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
    Stone JD; Stern LJ
    J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
    Carrabba MG; Castelli C; Maeurer MJ; Squarcina P; Cova A; Pilla L; Renkvist N; Parmiani G; Rivoltini L
    Cancer Res; 2003 Apr; 63(7):1560-7. PubMed ID: 12670905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.